Netflix is testing a feature that asks viewers to verify they share a household with the account holder, the company said on Thursday, a move that could lead to a clampdown on sharing of passwords.
Netflix is testing a feature that asks viewers to verify they share a household with the account holder, the company said on Thursday, a move that could lead to a clampdown on sharing of passwords.
PHILADELPHIA, April 12, 2021 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Champignon Brands Inc. (“Champignon” or the “Company”) (OTC: SHRMF) to determine whether the Company engaged in securities fraud or other unlawful business practices. On April 10, 2021, a class action lawsuit was filed in United States District Court, Central District of California, on behalf of Champignon investors who purchased, or otherwise acquired, Champignon securities between March 27, 2020 and February 17, 2021, both dates inclusive (the “Class Period”). According to the class action complaint, throughout the Class Period, the Champignon Defendants made false and/or misleading statements and/or failed to disclose that (1) Champignon had undisclosed material weaknesses and insufficient financial controls; (2) Champignon’s previously issued financial statements were false and unreliable; (3) Champignon’s earlier reported financial statements would need to be restated; (4) Champignon’s acquisitions involved an undisclosed related party; (5) as a result of the foregoing and subsequent reporting delays and issues, the British Columbia Securities Commission would suspend Champignon from trading; and (6) as a result, the Champignon Defendants’ statements about Champignon’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES DURING THE CLASS PERIOD AND SUFFERED SIGNIFICANT LOSSES ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, KCAULEY@KEHOELAWFIRM.COM, SECURITIES@KEHOELAWFIRM.COM, INFO@KEHOELAWFIRM.COM, TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS. Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors. This press release may constitute attorney advertising.
NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating claims of violations of federal securities laws on behalf of investors of Kadmon Holdings, Inc. ("Kadmon" or the "Company") (NASDAQ: KDMN). If you are a shareholder of Kadmon with more than $300,000 in losses, you should contact the Firm. Kadmon is a biopharmaceutical company that discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. The Company's lead product candidates include, among others, belumosudil (KD025), an orally administered selective inhibitor of the rho-associated coiled-coil kinase 2 ("ROCK2"), which is in Phase II clinical development for the treatment of chronic graft-versus-host disease ("cGVHD"). On September 30, 2020, post-market, Kadmon announced the submission of a New Drug Application ("NDA") for belumosudil for the treatment of cGVHD (the "Belumosudil NDA") with the U.S. Food and Drug Administration ("FDA"). Then, on November 30, 2020, Kadmon announced the FDA's acceptance of the Belumosudil NDA, and that the FDA had assigned the NDA a Prescription Drug User Fee Act ("PDUFA") target action date of May 30, 2021. On March 10, 2021, Kadmon issued a press release "announc[ing] that the [FDA] has extended the review period" for the Belumosudil NDA and that, "[i]n a notice received from the FDA on March 9, 2021, the Company was informed that the [PDUFA] goal date for its Priority Review of belumosudil has been extended to August 30, 2021." Kadmon advised investors that "[t]he FDA extended the PDUFA date to allow time to review additional information submitted by Kadmon in response to a recent FDA information request," and that "[t]he submission of the additional information has been determined by the FDA to constitute a major amendment to the NDA, resulting in an extension of the PDUFA date by three months." On this news, Kadmon's stock price fell $0.52 per share, or 10.57%, to close at $4.40 per share on March 11, 2021. If you are a shareholder of Kadmon who purchased Kadmon securities between October 1, 2020 and March 10, 2021, inclusive, you have until June 2, 2021 to ask the Court to appoint you as Lead Plaintiff for the class. To participate, learn more, or discuss the issues surrounding the investigation, please contact our attorneys at (914) 733-7256 or via email at email@example.com. Whistleblowers: Persons with non-public information regarding Kadmon should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. About Lowey Dannenberg Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors. Contact Lowey Dannenberg P.C.44 South Broadway, Suite 1100 White Plains, NY 10601Tel: (914) 733-7256Email: firstname.lastname@example.org
Does stock market volatility keep you up at night? Join Edelman Financial Engines for a special virtual event webinar that reveals how our new service offering, Downside Defense™ lets you invest in a diverse portfolio while helping protect your downside. At this event, we'll show you how this service works and how it can help give you peace of mind about your financial future.
* Graphic: World FX rates https://tmsnrt.rs/2RBWI5E (Adds Treasury auction results, comments from Fed's Rosengren, updates prices) By Karen Brettell NEW YORK, April 12 (Reuters) - The dollar dipped slightly on Monday as traders awaited highly anticipated U.S. inflation and retail sales data in coming days, and as the Treasury Department saw solid demand for new sales of three-year and 10-year notes. The dollar has rebounded this year as U.S. Treasury yields rise on expectations of faster economic growth and higher inflation. "With U.S. data expected to come in strong this week, we believe the dollar’s rise can continue," analysts at Brown Brothers Harriman said in a report on Monday.
Police chief says Mr Wright killed by “accidental discharge” that is under investigation
Powering Precision Health (PPH), the internationally acclaimed Summit focused on precision health and the latest in biomarker research, today announced that its Founder and Chairman, and CEO of Quanterix Kevin Hrusovsky, will lead a panel on Tuesday, April 13, 2021, at the Precision Medicine Leaders Summit’s (PMLS) virtual conference on Disrupting Precision Health with Next-Generation Proteomics.
NuStar Energy L.P. (NYSE: NS) announced today that for the 12th time it has been included on the list of the 100 Best Companies to Work For, according to Fortune magazine and global research and consulting firm Great Place to Work. NuStar is the only energy company to earn a ranking this year and is one of only two San Antonio-based companies on the list.
TORONTO, April 12, 2021 (GLOBE NEWSWIRE) -- As insolvency proceedings at Laurentian University continue, Ontario’s labour movement urges Premier Ford and Minister Ross Romano to step up and fix the crisis exacerbated by this government’s funding failures. “Today’s news that Laurentian University is laying off over 80 faculty members, numerous staff, and cutting over 60 programs is devastating,” said Patty Coates, Ontario Federation of Labour President. “This crisis was avoidable, and it is well past time for Ford and Romano to step up and provide the funding that Laurentian needs to save jobs, support learning, and fund research.” The crisis at Laurentian is merely a symptom of the much larger problem of chronic underfunding of Ontario’s post-secondary education system. Years of diminishing funding for colleges and universities paired with the Ford government’s refusal to provide any short-term funding relief has resulted in Laurentian University’s use of the CCAA process – a process reserved for private institutions, until now. “It is deeply concerning that Ford and Romano have not only refused to provide the long-term funding Ontario’s universities and colleges need, but they are also refusing to provide support when these public institutions are in crisis,” said Coates. Workers are particularly concerned about the far-reaching impacts of the use of the CCAA process by a public institution. “Ontarians should be able to trust their government to fund the public services they rely on,” said Coates. “There should not be fear that a school or a hospital might go bankrupt – yet this is the reality that we are living in under Ford’s Conservative government.” It is not too late for the Ontario government to step in, fix the crisis at Laurentian, and ensure that no other post-secondary institution or any other public institution faces the same fate. Ford and Romano must stop putting ideology over protecting the public institutions Ontarians rely on – especially in the midst of a pandemic. The Ontario Federation of Labour represents 54 unions and one million workers in Ontario. For information, visit www.OFL.ca and follow @OFLabour on Facebook and Twitter.For more information, please contact:Melissa Palermo Director of Communications Ontario Federation of Labourmpalermo@ofl.ca l 416-894-3456
Brazil's Petroleo Brasileiro SA reduced crude exports to China in the first quarter of 2021 as local refining margins improved, Roberto Castello Branco told Reuters in his last interview before stepping down as chief executive officer. China is the world's largest importer of crude oil, and had accounted for as much as 90% of Petrobras's international sales one year ago when the COVID-19 pandemic reduced mobility and corroded fuel demand in its home market.
ANNAPOLIS JUNCTION, Md., April 12, 2021 (GLOBE NEWSWIRE) -- Livanta LLC is pleased to announce its recent award of a national claim review task order under the Centers for Medicare & Medicaid Services’ (CMS) Beneficiary and Family Centered Care - Quality Improvement Organization (BFCC-QIO) program. The BFCC-QIO claim review function is derived from Part B of Title XI of the Act and the QIO regulations in 42 CFR Parts 475, 476 and 480. Funded through the CMS Center for Clinical Standards & Quality (CCSQ), this 54-month task order supports CMS in its core functions of beneficiary oversight and protection of the Medicare Trust Fund across all 50 states, five United States territories, and the District of Columbia. The BFCC-QIO claim review task order serves to decrease CMS’ paid claims error rate. Livanta will perform specific types of utilization reviews for proper payment of Medicare claims involving hospital inpatient admissions of short duration and where hospitals re-submitted certain types of inpatient claims for a higher payment than what they had billed initially. As part of the review, Livanta will evaluate whether the services performed were medically necessary and at the appropriate level of care. As part of its claim review activities, Livanta will provide education services to help hospitals improve their billing accuracy; analyze claims and other data to select samples for review; issue payment determination notices; notify companies that pay the claims for Medicare when hospitals need to refund payments or make other claim adjustments; and perform outreach functions with hospital providers, beneficiaries, and other stakeholders to help safeguard the Medicare trust fund against fraud, waste, and abuse. Livanta’s Chief Medical Officer, Ellen R. Evans, MD, a Board-certified Family Physician and Geriatrician, stated, “The Livanta team of clinicians brings exemplary experience, knowledge, understanding, and skill to this workload. Over the long months of the ongoing pandemic, our work as a Medicare Beneficiary and Family Centered Care - Quality Improvement Organization continually reveals the strength, stamina, innovation, and determination that every Medicare beneficiary, caregiving family, and healthcare provider brings to our nation. Throughout this unprecedented healthcare crisis, those we serve inspire us to provide Medicare with the highest quality of claim review services.” About Livanta LLC: Livanta LLC, established in 2004, is a privately-held, government contracting firm headquartered in Annapolis Junction, MD. The company’s success lies within its team of knowledgeable professionals who are committed to providing excellent service and quality products powered by exceptional IT solutions and data analytics. ContactLeasa NovakLNovak@Livanta.com This material was prepared by Livanta LLC, the Medicare Beneficiary and Family Centered Care - Quality Improvement Organization (BFCC-QIO) that provides Beneficiary Oversight Claim Review Services, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents presented do not necessarily reflect CMS policy. 12-SOW-MD-2021-QIOBFCC-TO31
GN Store Nord A/S hereby announces that on April 12, 2021, pursuant to Section 38(1) of the Danish Capital Markets Act, it received a notification from BlackRock, Inc. stating that on April 9, 2021 BlackRock, Inc. held shares and financial instruments, cf. Section 38 and Sections 39(2)(1) and (2) of the Danish Capital Markets Act, representing 5.00% and 0.06%, respectively, (in aggregate 5.06%) of the share capital and voting rights in GN Store Nord A/S. For further information, please contact: Investors and analystsHenriette WennickeVice President – Investor Relations & TreasuryTel: +45 45 75 03 33 Or Rune SandagerDirector – Investor Relations & Treasury Tel: +45 45 75 92 57 Press and the media Lars Otto Andersen-Lange Head of Media Relations & Corporate Public Affairs Tel: +45 45 75 02 55 About GN Group The GN Group enables people to Hear More, Do More and Be More through its intelligent hearing, audio and video collaboration solutions. Inspired by people and driven by our innovation leadership, we leverage technological synergies between our hearing and audio divisions to deliver unique and increasingly individualized user experiences in our products and solutions. 150 years ago, GN was founded with a truly innovative and global mindset. Today, we honor that legacy with world-leading expertise in the human ear, sound and video processing, wireless technology, miniaturization and collaborations with leading technology partners. GN's solutions are marketed by the brands ReSound, Beltone, Interton, Jabra, BlueParrott and FalCom in 100 countries. Founded in 1869, the GN Group employs 6,500 people and is listed on Nasdaq Copenhagen (GN.CO). Visit our homepage GN.com - and connect with us on LinkedIn, Facebook and Twitter. Attachment Announcement 9 - Major shareholder notification
Google's Nest Audio is on sale for $20 off at many online retailers, including Best Buy and Walmart.
Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired 3D Systems Corporation ("3D Systems" or the "Company") (NYSE: DDD) securities between May 6, 2020 and March 1, 2021, inclusive (the "Class Period"). 3D Systems investors have until June 8, 2021 to file a lead plaintiff motion.
The report comes within an hour of the Twins postponing their game.
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Immunosuppressive drugs for inflammatory diseases like rheumatoid arthritis, multiple sclerosis, and ulcerative colitis can impair the body's response to the COVID-19 vaccines from Pfizer/BioNTech and Moderna, according to new data. In 133 fully vaccinated people with such conditions, antibody levels and virus neutralization were about three-fold lower than in a comparison group of vaccinated individuals not taking those medicine, researchers reported on Friday on medRxiv ahead of peer review.
LendCare is one of Canada’s leading point-of-sale consumer financing providersStrategic acquisition accelerates growth through product and point-of-sale channel expansionAttractive valuation and synergies to assist in producing long-term return on equity of 25%+High return business will contribute to history of compounding earnings growth at over 30%Transaction expected to be immediately accretive to adjusted earnings per share, increasing to ~10% in 2022 and ~15% in 2023 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MISSISSAUGA, Ontario, April 12, 2021 (GLOBE NEWSWIRE) -- goeasy Ltd. (TSX: GSY), (“goeasy” or the “Company”), a leading full-service provider of goods and alternative financial services, announced today that it has entered into a definitive agreement to acquire LendCare Holdings Inc. (“LendCare”), a Canadian point-of-sale consumer finance and technology company, from LendCare’s founders and CIVC Partners (the “Acquisition”). goeasy has agreed to acquire LendCare for $320 million, payable in a combination of cash and $10 million in common shares elected to be received by LendCare’s founders as part of their consideration, at closing. The Acquisition is expected to close in the second quarter of 2021, subject to customary closing conditions and regulatory approvals. The Acquisition of LendCare is expected to accelerate goeasy’s growth in the consumer credit market through the expansion of its product range and point-of-sale distribution platform. Founded in 2004, LendCare is one of Canada’s leading point-of-sale financing providers, with approximately 3,000 merchant, OEM and distributor relationships nationwide. Through its proprietary origination software, LendCare specializes in financing consumer purchases in the powersports, automotive, retail, healthcare, and home improvement verticals. “We are pleased to be executing an acquisition with such strong strategic fit. Each year in Canada there is estimated to be more than $40 billion of credit extended to consumers through financing and “buy-now, pay-later” programs offered at the point-of-sale. Through this acquisition, we will strengthen our position as a leading provider of non-prime consumer credit, while also expanding our range of near-prime products and adding new industry verticals to our point-of-sale lending channel,” said Jason Mullins, goeasy’s President & Chief Executive Officer, “The transaction is expected to accelerate our existing growth strategy, while providing immediate accretion to our adjusted earnings per share and contributing to our 20 year track record of compounding earnings growth at over 30%.” “The Board of Directors is highly supportive of this transaction, as it meets all of our key investment criteria for capital allocation,” said David Ingram, goeasy’s Executive Chairman of the Board, “The Company is planning to maintain a prudent leverage profile beneath our target level of 70% net debt to net capitalization, while positioning itself to continue producing attractive long-term total returns for shareholders.” In 2020, LendCare produced income before taxes, calculated under accounting standards for private enterprises (“ASPE”), of approximately $19 million and had approximately $400 million in consumer loans receivable as of December 31, 2020. The purchase price of the Acquisition implies a multiple of approximately 13x the anticipated 2021 earnings of LendCare, calculated under international financial reporting standards (“IFRS”) after adjusting for certain items,1 as well as excluding the anticipated synergy opportunities. Revenue, funding, and cost synergies are expected to be realized primarily from optimizing credit and pricing to produce increased originations, cross-selling products to consumers, reducing the funding costs of the business and delivering back-office efficiencies. The Acquisition is aligned with goeasy’s financial objectives and is anticipated to be immediately accretive to the Company’s adjusted earnings per share1, with accretion expected to increase to approximately 10% in 2022 and approximately 15% in 2023. As part of the Acquisition, LendCare’s founders, Ali Metel and Mark Schell, will assume management positions with goeasy, while maintaining responsibility for the ongoing operations of LendCare. “After building a leading point-of-sale financing platform over the last 15 years, we are excited for the next chapter of our growth with goeasy,” said Ali Metel, LendCare President & CEO, “Together, we offer a wide diversification of products and distribution channels across the consumer lending market that can help deliver a premium experience for our customers. We look forward to leveraging the combined expertise and technology of each firm, and the benefits of the scale and investment goeasy will bring to the LendCare platform.” Bought Deal Equity Offering of Subscription Receipts In conjunction with the Acquisition, the Company has entered into an agreement with a syndicate of underwriters (the “Underwriters”) led by BMO Capital Markets to issue, on a bought deal basis, 1,060,000 subscription receipts (the “Subscription Receipts”), at a price of $122.85 per Subscription Receipt, for gross proceeds of approximately $130 million, to finance a portion of the purchase price for the Acquisition (the “Offering”). Additional information about the Offering is set out below under “Additional Information on the Offering of Subscription Receipts.” Debt Financing In connection with the Acquisition, BMO Capital Markets has provided the Company with fully committed debt financing. The Company intends to issue new senior unsecured notes prior to closing of the Acquisition. Immediately following the Acquisition, the Company expects to have net debt to net capitalization of below 70% and net debt to tangible net worth2 of approximately 4.0x. Given the strong free cash flow generation of the business, the Company intends to de-lever to approximately 3.0x by the end of fiscal 2023. The Company maintains a strong liquidity profile and, based on the expected borrowing capacity under the Company’s credit facilities and cash on hand, estimates it will have approximately $600 million in total funding capacity immediately after closing of the Acquisition. Select Preliminary Unaudited Financial Results for the First Quarter Ended March 31, 2021 The Company has also announced select preliminary unaudited financial results for the first quarter ended March 31, 2021 based on information currently available to management. The Company is making this announcement because the same information is being provided concurrently to potential investors in connection with the Offering. The Company anticipates that the financial results for the first quarter of 2021 will include the following highlights: Loan originations in the first quarter of 2021 were $272 million, up 12% from $242 million in the first quarter of 2020Loan book growth in the first quarter of 2021 was approximately $30.5 million, resulting in an ending consumer loan receivable of $1.28 billionThe annualized net charge-off rate for the quarter was 9.1%, down from 13.2% in the first quarter of 2020An $89.4 million unrealized gain was recognized in the first quarter of 2021, related to the Company’s investment in Affirm, including the unrealized gain from a total return swap hedging instrument All figures reported above with respect to the first quarter of 2021 are preliminary and are subject to change and adjustment as the Company's financial results for the first quarter ended March 31, 2021 are finalized. Accordingly, investors are cautioned not to place undue reliance on the foregoing guidance. The Company does not intend to provide unaudited preliminary results in the future. The preliminary unaudited results provided in this news release constitute forward-looking statements within the meaning of applicable securities laws, are based on several assumptions and are subject to a number of risks and uncertainties. Actual results may differ materially. Please see the section below entitled "Forward-Looking Statements". Investor Call Management of goeasy will host a conference call on April 12, 2021 at 3:50 p.m. EST to discuss the Acquisition. The conference call is open to all investors. Participant Toll-Free Dial-In Number: (866) 219-5269Participant International Dial-In Number: (703) 736-7431Password: 4256856Webcast: https://edge.media-server.com/mmc/p/8cfb9o42 After the conference call, a recording will be available by calling 1-855-859-2056 and entering passcode number 4256856. A supplemental presentation will also be available on the Company’s investor website at https://investors.goeasy.com/events-and-presentations/presentations Advisors and Counsel BMO Capital Markets and Raymond James Ltd. are acting as financial advisors to goeasy. Blake, Cassels & Graydon LLP is acting as legal counsel to goeasy in connection with the Acquisition. National Bank Financial Inc. and Keefe, Bruyette & Woods, A Stifel Company, are acting as financial advisors to LendCare. Stikeman Elliott LLP is acting as legal counsel to LendCare in connection with the Acquisition. Osler, Hoskin & Harcourt LLP is acting as legal counsel to the syndicate of underwriters. Additional Information on the Offering of Subscription Receipts The Company has also granted the Underwriters an option to purchase up to an additional 159,000 Subscription Receipts on the same terms and conditions, exercisable at any time, in whole or in part, up to the earlier of (i) 30 days after the closing of the Offering and (ii) the termination of Acquisition. If the closing of the Acquisition occurs on or prior to the closing of the overallotment option, the Company will deliver common shares, instead of Subscription Receipts, to investors on closing of the overallotment option. Upon the satisfaction or waiver of each of the conditions precedent to the closing of the Acquisition (other than the payment of the consideration for the Acquisition and such other conditions precedent that, by their nature, are to be satisfied at the time of closing of the Acquisition): (a) one common share will be automatically issued in exchange for each Subscription Receipt (subject to customary anti-dilution protection), without payment of additional consideration or further action by the holder thereof; (b) an amount per Subscription Receipt equal to the per-share cash dividends declared by the Company on the common shares to holders of record on a date during the period that the Subscription Receipts are outstanding, net of any applicable withholding taxes, will become payable in respect of each Subscription Receipt; and (c) the net proceeds from the sale of the Subscription Receipts will be released from escrow to the Company for the purposes of completing the Acquisition. The net proceeds from the sale of the Subscription Receipts will be held by an escrow agent pending the fulfillment or waiver of all outstanding conditions precedent to closing of the Acquisition (other than the payment of the consideration for the Acquisition). There can be no assurance that the applicable closing conditions will be met or that the Acquisition will be consummated. If the Acquisition is not completed as described above by December 1, 2021 or if the Acquisition is terminated at an earlier time, the gross proceeds of the Offering and pro rata entitlement to interest earned or deemed to be earned on the gross proceeds of the Offering, net of any applicable withholding taxes, will be paid to holders of the Subscription Receipts, and the Subscription Receipts will be cancelled. The Subscription Receipts will be offered pursuant to a prospectus supplement to the Company’s short-form base shelf prospectus dated November 23, 2020, which prospectus supplement is expected to be filed in each of the provinces of Canada, except Québec, on or about April 13, 2021. Further information regarding the Offering and the Acquisition, including related risk factors, will be set out in the prospectus supplement. The Offering is expected to close on or about April 16, 2021 and is subject to certain conditions including, but not limited to, the approval of the Toronto Stock Exchange. The Subscription Receipts and the underlying common shares have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, (the "1933 Act") and may not be offered, sold or delivered, directly or indirectly, in the United States, or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the 1933 Act), except pursuant to an exemption from the registration requirements of the 1933 Act. This press release does not constitute an offer to sell or a solicitation of an offer to buy any Subscription Receipts or the underlying common shares in the United States or to, or for the account or benefit of, U.S. persons. About goeasy goeasy Ltd., a Canadian company, headquartered in Mississauga, Ontario, provides non-prime leasing and lending services through its easyhome and easyfinancial divisions. With a wide variety of financial products and services including unsecured and secured instalment loans, goeasy aspires to help put Canadians on a path to a better financial future, as they rebuild their credit and graduate to prime lending. Customers can transact seamlessly with easyhome and easyfinancial through an omni-channel model that includes online and mobile, as well as over 400 leasing and lending locations across Canada supported by more than 2,000 employees. Throughout the company’s history, it has served over 1 million Canadians and originated $5.0 billion in loans, with one in three customers graduating to prime credit and 60% increasing their credit score within 12 months of borrowing. Accredited by the Better Business Bureau, goeasy is the proud recipient of several awards including Waterstone Canada’s Most Admired Corporate Cultures, Glassdoor Top CEO Award, Achievers Top 50 Most Engaged Workplaces in North America, Greater Toronto Top Employers Award, the Digital Finance Institute’s Canada’s Top 50 FinTech Companies, ranking on the TSX30 and placing on the Report on Business ranking of Canada’s Top Growing Companies. The company and its employees believe strongly in giving back to the communities in which it operates and has raised over $3.5 million to support its long-standing partnerships with BGC Canada, Habitat for Humanity and many other local charities. goeasy’s common shares are listed on the TSX under the trading symbol “GSY”. goeasy is rated BB- from S&P and Ba3 from Moody’s. Visit www.goeasy.com. About LendCare LendCare is a Canadian point-of-sale consumer finance and technology company, which enables 3,000 businesses to increase their revenue by providing full credit spectrum financing at the point-of-sale. For over a decade, LendCare has cleared a path to providing fast, reliable and affordable financing options for the powersports, auto, retail, home improvement and health sectors, while processing over $6 billion in loan applications to date. With a dedicated team of finance experts and well-established partnerships with merchants, dealerships and brokers, LendCare bridges the gap between credit score and customers living their best life. Forward-Looking Statements Certain information herein constitutes “forward-looking information” as defined under Canadian securities laws which reflect management’s expectations regarding objectives, plans, goals, strategies, future growth, results of operations, performance, business prospects and opportunities of the Company. Some of the specific forward-looking statements contained herein include, but are not limited to, statements with respect to the intention of the Company to complete the closing of the Acquisition, the Offering and the related transactions contemplated herein on the terms and conditions described herein, the effect of the Acquisition, the Offering and the related transactions contemplated herein on the financial performance of the Company, the other anticipated benefits of the Acquisition, the Offering and the related transactions contemplated herein, the expected timing for completion of the Acquisition, the preliminary financial results for the first quarter of 2021 contained herein, the expected debt financing and the Company’s expected leverage and future liquidity profile, the closing date of the Offering and the use of proceeds of the Offering. The words “plans”, “expects”, “does not expect”, “scheduled”, “estimates”, “intends”, “anticipates”, “does not anticipate”, “projects”, “believes”, or variations of such words and phrases or statements to the effect that certain actions, events or results “may”, “will”, “could”, “would”, “might”, “occur”, “be achieved”, or “continue” and similar expressions identify forward-looking statements. Such forward-looking statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable by management as of the date hereof, are inherently subject to significant business, economic and competitive uncertainties and contingencies. When relying on forward-looking statements to make decisions, readers are cautioned not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not the times at or by which such performance or results will be achieved. A number of factors, including the risks described under the heading “Risk Factors” in our annual information form and management’s discussion and analysis for the year ended December 31, 2020 filed on SEDAR and described under the heading “Risk Factors” in our material change report dated April 12, 2021 to be filed on SEDAR, could cause actual results to differ materially from the results discussed in the forward-looking statements. Additional information about risks and uncertainties is contained in the other filings of the Company with securities regulators. For further information contact: Jason MullinsPresident & Chief Executive Officer(905) 272-2788 Farhan Ali KhanSenior Vice President, Corporate Development & Investor Relations(905) 272-2788 _____________________________1 Adjusted earnings refer to earnings excluding Acquisition-related transaction expenses and the amortization of acquired intangibles, as well as a one-time provision under IFRS related to the Acquisition.2 Net debt to tangible net worth is equal to (debt minus qualified cash / shareholders’ equity minus intangibles, goodwill, and deferred financing costs).
* Ecuador bonds hit 7-month high * Guillermo Lasso wins presidential runoff in Ecuador * Peruvian sol ends flat as cenbank intervenes to stop slide * Far-left Peruvian presidential candidate set to win first round (Updates prices, adds comment) By Susan Mathew April 12 (Reuters) - Bonds in Ecuador rallied to a seven month high on Monday after banker Guillermo Lasso pulled off a surprise win in Sunday's presidential runoff against socialist economist Andres Arauz, while central bank intervention cushioned Peru's sol. The sol and Peruvian stocks had tumbled earlier in the session after a far-left candidate, Pedro Castillo, won the first round of Peru's presidential election on Sunday.
Myanmar's detained government leader Aung San Suu Kyi has asked a court to be allowed to meet her lawyers in person when she appeared at a hearing via video link to face charges brought by the military junta.As Suu Kyi appeared, her supporters called for people to show their opposition to the February 1 coup during this week's traditional new year holiday in the largely Buddhist country.
Please send your letters to email@example.com
NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating claims of violations of federal securities laws on behalf of investors of Arcimoto Inc. (“Arcimoto” or the “Company”) (NASDAQ: FUV). If you are a shareholder of Arcimoto with more than $300,000 in losses, you should contact the Firm. On March 23, 2021, Bonitas Research published a short-seller report on Arcimoto. In the report, Bonitas alleges that Arcimoto fabricated pre-orders to generate fake demand, only delivered on 19 of the 422 alleged pre-orders since 2018, sold 13 of the 19 pre-orders to an undisclosed related party, and failed to notify customers that Arcimoto filed a total production recall notice with the United States Government’s federal agency, the National Highway Traffic Safety Administration. Arcimoto’s shares dropped by $1.10, or approximately 6.56%, from closing at $16.77 on March 22, 2021 to close at $15.67 on March 23, 2021. If you are a shareholder of Arcimoto, and wish to participate, learn more, or discuss the issues surrounding the investigation, please contact our attorneys at (914) 733-7256 or via email at firstname.lastname@example.org. Whistleblowers: Persons with non-public information regarding Arcimoto should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. About Lowey Dannenberg Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors. Contact Lowey Dannenberg P.C.44 South Broadway, Suite 1100 White Plains, NY 10601Tel: (914) 733-7256Email: email@example.com